IRWD is trading 6.7% up at $4.77 in after-hours trading, extending its recent rebound from late-June lows on sustained technical momentum.

  • The move appears driven by short-term trading interest following several days of steady gains, with no new earnings, FDA decisions, or M&A activity reported.
  • IRWD's strength is notably stock-specific, as broader market indices remained mixed during the session.
  • The price action continues a recovery trend after the stock hit recent lows in late June 2026.